首页> 外文期刊>Frontiers in Pharmacology >Antidiabetic and Antilipidemic Effect of Musa balbisiana Root Extract: A Potent Agent for Glucose Homeostasis in Streptozotocin-Induced Diabetic Rat
【24h】

Antidiabetic and Antilipidemic Effect of Musa balbisiana Root Extract: A Potent Agent for Glucose Homeostasis in Streptozotocin-Induced Diabetic Rat

机译:斜纹麝香根提取物的抗糖尿病和降血脂作用:链脲佐菌素诱导的糖尿病大鼠葡萄糖稳态的有效剂。

获取原文
           

摘要

Folklore studies have revealed that Musa balbisiana Colla (MB; Family: Musaceae) has high medicinal properties. The purpose of the present study is to evaluate antihyperglycemic, and antioxidant activity of MB extracts in streptozotocin (STZ) induced diabetic rats. In vitro antioxidant and antidiabetic activity of MB extracts, i.e., root extract (RE), shoot extract and inflorescence extract were determined by using various methods viz 1,-1-diphenyl-2-picrylhydrazyl (DPPH) and a method to assess their possible effect on glucose diffusion across gastrointestinal tract and identify bioactive compound of potent extract. In vivo antilipidemic and antidiabetic activity was evaluated by administrating oral dose of RE for 15 days on STZ- induced diabetic rat. RE showed highest antioxidant activity by scavenging DPPH radical (IC50 32.96 μg/ml) and inhibit 30% glucose movement in vitro . The methanol extract of root showed the presence of calyx [4] arene category of the compound. Furthermore, RE treated rat revealed a reduction in fasting blood glucose (62.5%), serum total cholesterol (36.2%), triglyceride (54.5%), and low-density lipoprotein (50.94%) after 15 days as compared to STZ treated animal. There was an initiation of regenerative structures of the affected organs after 15 days of RE treatment. Histopathological observations clearly differentiate the structural changes in pancreas, liver, and kidney of STZ and RE treated group. The presence of calyx [4] arene class of compound may be responsible for its antioxidant and antidiabetic properties by absorbing glucose in vivo .
机译:民间文学研究表明,Mus balbisiana Colla(MB;家族:Musaceae)具有很高的药用特性。本研究的目的是评估链脲佐菌素(STZ)诱导的糖尿病大鼠中MB提取物的降血糖和抗氧化活性。 MB提取物,即根提取物(RE),芽提取物和花序提取物的体外抗氧化和抗糖尿病活性通过多种方法测定,即1,-1-二苯基-2-picylhydrazyl(DPPH)及其评估方法。影响葡萄糖在胃肠道中的扩散,并确定有效提取物的生物活性化合物。通过在STZ诱导的糖尿病大鼠上口服RE的剂量达15天来评估体内抗血脂和抗糖尿病活性。 RE通过清除DPPH自由基(IC50 32.96μg/ ml)表现出最高的抗氧化活性,并在体外抑制30%的葡萄糖运动。根的甲醇提取物显示该化合物存在花萼[4]芳烃类别。此外,与STZ处理的动物相比,RE处理的大鼠在15天后显示空腹血糖(62.5%),血清总胆固醇(36.2%),甘油三酸酯(54.5%)和低密度脂蛋白(50.94%)减少。 RE治疗15天后,受影响器官开始再生。组织病理学观察清楚地区分了STZ和RE治疗组的胰腺,肝脏和肾脏的结构变化。花萼[4]芳烃类化合物的存在可能是通过体内吸收葡萄糖来实现其抗氧化和抗糖尿病作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号